The Open Science Forum features monthly talks from scientists from NIH-funded Antiviral Drug Discovery (AViDD) Centers who elect to provide updates on target priorities, advertise available resources and reagents, disclose chemical matter and associated antiviral data, share findings regarding in vivo efficacy models, discuss downstream development and translation models, and share ideas.
Presentation
Moderator: Peter Sjö, Head of Drug Discovery Programme, DNDi
| Thiago Moreno L. Souza, Research Specialist, Center for Technological Development in Health (CDTS/Fiocruz) |
| Understanding SARS-CoV-2 Variants through Reverse Genetics Melanie Ott, Senior Investigator, UCSF |
